by GlobeNewsWire | Sep 1, 2016 | Globe Newswire
DURHAM, N.C., Sept. 01, 2016 (GLOBE NEWSWIRE) — Argos Therapeutics Inc. (Nasdaq:ARGS) (“Argos”), an immuno-oncology company focused on the development and commercialization of truly individualized immunotherapies based on the Arcelis® technology platform, today...
by GlobeNewsWire | Sep 1, 2016 | Globe Newswire
LAGUNA HILLS, Calif., Sept. 01, 2016 (GLOBE NEWSWIRE) — PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology,...
by GlobeNewsWire | Sep 1, 2016 | Globe Newswire
PLYMOUTH MEETING, Pa., Sept. 01, 2016 (GLOBE NEWSWIRE) — Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that the Company will present a corporate overview at the following upcoming conferences: Citi 11th Annual Biotech ConferenceMandarin Oriental,...
by GlobeNewsWire | Sep 1, 2016 | Globe Newswire
BERKELEY, Calif., Sept. 01, 2016 (GLOBE NEWSWIRE) — Aduro Biotech, Inc. (Nasdaq:ADRO) today announced the opening of a new corporate office and laboratory facility, which will serve as the company’s new global headquarters for its U.S. and European operations....
by GlobeNewsWire | Aug 31, 2016 | Globe Newswire
IRVINE, Calif., Aug. 31, 2016 (GLOBE NEWSWIRE) — MRI Interventions, Inc. (OTCQB:MRIC) today announced it has entered into a definitive securities purchase agreement with a group of investors, which will result in gross proceeds to MRI Interventions of...